Positive Results Presented From Phase 2 Clinical Trial Of Biothera's Imprime PGG Cancer Immunotherapy In Non-Small Lung Cancer Patients
1/8/2014 9:33:27 AM
EAGAN, Minn.--(BUSINESS WIRE)--Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.
Help employers find you! Check out all the jobs and post your resume.
comments powered by